NFKB1 and glioblastoma: We show here that mTOR signalling increases STAT3 activity and inhibits NF‐κB in TAM‐MG in different GBM models, therefore hampering APC immune reactivity as well as effector T‐cell proliferation and immune response via the expression of anti‐inflammatory cytokines.